Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/1995
07/27/1995WO1995019970A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995WO1995019968A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
07/27/1995WO1995019964A1 Ep2-receptor agonists as agents for lowering intraocular pressure
07/27/1995WO1995019961A1 Metalloproteinase inhibitors
07/27/1995WO1995019960A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
07/27/1995WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
07/27/1995WO1995019958A1 Malarial aspartic protease inhibitors
07/27/1995WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995WO1995019956A1 Metalloproteinase inhibitors
07/27/1995WO1995019775A1 A pharmaceutical composition with improved bio-availability of inositol phosphate
07/27/1995WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995WO1995019772A1 Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
07/27/1995WO1995019771A1 Indole diterpene alkaloid compounds
07/27/1995WO1995019767A1 Guanylhydrazones for treating inflammatory conditions
07/27/1995WO1995019706A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995WO1995017910A3 Paramagnetic diagnostic formulations and their method of use
07/27/1995WO1995014778A3 Dna sequence coding for a bmp receptor
07/27/1995WO1995009848A3 Polyazacycloalkanes as dichelants
07/27/1995CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995CA2181592A1 Pore forming peptides from geolycosa riogrande
07/27/1995CA2181551A1 Malarial aspartic protease inhibitors
07/27/1995CA2181431A1 Haemopoietic maturation factor
07/27/1995CA2181371A1 Indole diterpene alkaloid compounds
07/27/1995CA2181031A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995CA2180956A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
07/27/1995CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995CA2126361A1 Gene encoding cationic amino acid transporter protein
07/26/1995EP0664289A2 Isoquinolines
07/26/1995EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives
07/26/1995EP0664126A1 Inhibition of thrombin
07/26/1995EP0664125A1 Inhibition of myeloperoxidase activity
07/26/1995EP0664122A1 Inhibition of imperfect tissue repair
07/26/1995EP0664121A1 Inhibition of ldl oxidation and atherosclerosis
07/26/1995EP0664117A1 Liposome solutions
07/26/1995EP0663954A1 Ptp 1d: a novel protein tyrosine phosphatase
07/26/1995EP0663918A1 Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors
07/26/1995EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
07/26/1995EP0663911A1 Benzopyranones, method of preparing them and their use.
07/26/1995EP0663902A1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
07/26/1995EP0663900A1 Metal-oxime chelates for use as radiopharmaceutical agents
07/26/1995EP0663832A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
07/26/1995EP0663822A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
07/26/1995EP0416037B1 Superoxide dismutase analogs having novel binding properties
07/26/1995CA2140701A1 Liposome solutions
07/25/1995US5436343 Thromboxane A2 receptor antagonist, thromoboxane A2 synthase inhibitor
07/25/1995US5436337 Anticarcinogenic agents
07/25/1995US5436261 Benzospiroalkene heterocyclic compounds
07/25/1995US5436258 Prevention of bone resorption
07/25/1995US5436253 Pyridonecarboxylic acid derivatives and mycotic infections
07/25/1995US5436246 Serotonin receptor agents
07/25/1995US5436245 Phosphate substituted amino or imino acids useful as antihypertensives
07/25/1995US5436235 3-aryl-glycidic ester derivatives
07/25/1995US5436233 Nervous system disorders
07/25/1995US5436231 Hypertensive agents
07/25/1995US5435999 Cytokines for cell proliferation
07/25/1995CA2140722A1 Beta-carboline thromboxane synthase inhibitors
07/25/1995CA2140709A1 Substituted arylureas
07/25/1995CA1336436C Gamma aminobutyric acid agonists and their use in the treatment of depression and senile dementia and other forms of memory impairment
07/25/1995CA1336433C Method for preparing phosphinic acids used in preparing ace inhibitors and intermediates produced thereby
07/25/1995CA1336431C Thiazolo(5,4-b)azepine compounds
07/25/1995CA1336412C Pharmaceutical composition having synergistic effect
07/25/1995CA1336411C Veterinary composition containing cloxacillin
07/25/1995CA1336409C Tumor or cancer cell killing therapy and agents useful therefor
07/25/1995CA1336398C Method for reducing side effects of cancer therapy
07/20/1995WO1995019436A1 Mammalian monocyte chemoattractant protein receptors
07/20/1995WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/20/1995WO1995019356A1 Endopeptidase 24.15 inhibitor
07/20/1995WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists
07/20/1995WO1995019177A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors
07/20/1995WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis
07/20/1995CA2181444A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors
07/20/1995CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis
07/20/1995CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists
07/19/1995EP0663398A1 Dihydrate of N-(4-amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-N'-(tetrahydrofuroyl-2)-propylene diamine hydrochloride (= alfuzosin hydrochloride dihydrate) and a process for the preparation
07/19/1995EP0663393A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors
07/19/1995EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof
07/19/1995EP0663007A1 Trophic factor having ion channel-inducing activity in neuronal cells
07/19/1995EP0662965A1 1,2-disubstituted ethyl amides as inhibitors of acat
07/19/1995EP0662959A1 5-ht4 antagonists
07/19/1995EP0662950A1 Benzenealkanoic acids for cardiovascular diseases
07/19/1995EP0662948A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
07/19/1995EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
07/19/1995EP0662818A1 Cosmetic composition containing retinol
07/19/1995EP0424416B1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
07/19/1995CN1105361A Methods for exhibiting angiogenisis and angiogenic diseases
07/19/1995CN1105360A 1-|2H-1-benzopyran-2-one-8yl¨-piperazin derivative
07/19/1995CN1105358A N-substituted azabicycloheptane derivatives, the preparation and use thereof
07/19/1995CN1105271A Pharmaceutical composition and process
07/19/1995CA2140498A1 Method for preventing or reducing risk of onset of cardiovascular events employing an hmg coa reductase
07/18/1995US5434245 Osteocalcin
07/18/1995US5434180 Skin disorders; retinoid activity; rheumatoid psoriasis;
07/18/1995US5434174 Isoxazole derivatives for the treatment of irritable bowel syndrome
07/18/1995US5434169 Piperidine derivatives, their preparation and their application in therapy
07/18/1995US5434167 Imidazolines N-substituted by a biphenylmethyl group, their medical use and the pharmaceutical compositions therefor
07/18/1995US5434161 Imidazopyridines as serotonergic 5-HT3 antagonists
07/18/1995US5434158 Asthma
07/18/1995US5434151 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
07/18/1995US5434149 Phosphodiesterase inhibitors
07/18/1995US5434145 N-alkythio polyamine derivatives as radioprotective agents
07/18/1995US5434135 Growth factor compositions, preparation and use
1 ... 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 ... 1564